世界のビジョンケア機器開発動向:医療機器パイプライン分析2015

◆英語タイトル:Vision Care - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0135EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年1月1日
◆ページ数:213
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,356,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、ビジョンケア機器のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・ビジョンケア機器の概要
・ビジョンケア機器の開発動向:開発段階別分析
・ビジョンケア機器の開発動向:セグメント別分析
・ビジョンケア機器の開発動向:領域別分析
・ビジョンケア機器の開発動向:規制Path別分析
・ビジョンケア機器の開発動向:承認日(推定)別分析
・企業別ビジョンケア機器の開発動向(パイプライン製品、進行中の治験)
・ビジョンケア機器の最近動向
【レポートの概要】

Vision Care – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Vision Care – Medical Devices Pipeline Assessment, 2015″ provides an overview of Vision Care currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vision Care pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vision Care under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vision Care and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vision Care under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Vision Care Overview 13
3 Products under Development 15
3.1 Vision Care – Pipeline Products by Stage of Development 15
3.2 Vision Care – Pipeline Products by Segment 16
3.3 Vision Care – Pipeline Products by Territory 17
3.4 Vision Care – Pipeline Products by Regulatory Path 18
3.5 Vision Care – Pipeline Products by Estimated Approval Date 19
3.6 Vision Care – Ongoing Clinical Trials 20
4 Vision Care – Pipeline Products under Development by Companies 21
4.1 Vision Care Companies – Pipeline Products by Stage of Development 21
4.2 Vision Care – Pipeline Products by Stage of Development 24
5 Vision Care Companies and Product Overview 27
5.1 Adventus Technology Inc Company Overview 27
5.1.1 Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Alcon, Inc. Company Overview 28
5.2.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Ophthalmics Company Overview 32
5.3.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Auburn University Company Overview 34
5.4.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Axcelon Biopolymers Corp. Company Overview 35
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Bar-Ilan University Company Overview 36
5.6.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Bausch & Lomb Incorporated Company Overview 38
5.7.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Belfanti – Fureder – Meidl technisches Buro f Elektro u Haustechnik GmbH Company Overview 42
5.8.1 Belfanti – Fureder – Meidl technisches Buro f Elektro u Haustechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Bionic Vision Australia Company Overview 43
5.9.1 Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Body Organ Biomedical Corp. Company Overview 48
5.10.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Children’s Hospital Boston Company Overview 50
5.11.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 Consejo Superior de Investigaciones Cientificas Company Overview 51
5.12.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 CooperVision, Inc. Company Overview 53
5.13.1 CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Cornell University Company Overview 54
5.14.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 EP Global Communications, Inc. Company Overview 55
5.15.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 eSight Corporation Company Overview 56
5.16.1 eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Euclid Systems Corporation Company Overview 57
5.17.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Eyegenix Company Overview 58
5.18.1 Eyegenix Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 EyeNetra, Inc. Company Overview 59
5.19.1 EyeNetra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.20 Eyenovations Company Overview 60
5.20.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 60
5.21 EyeYon Medical Company Overview 61
5.21.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.22 Imperial College London Company Overview 65
5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 iSTAR Medical Company Overview 66
5.23.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Johnson & Johnson Vision Care, Inc. Company Overview 67
5.24.1 Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.25 Massachusetts Eye and Ear Infirmary Company Overview 72
5.25.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
5.26 Medisse BV Company Overview 73
5.26.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 73
5.27 Mercy Research and Development Company Overview 74
5.27.1 Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview 74
5.28 Microbiosensor Ltd Company Overview 76
5.28.1 Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
5.29 Monash University Company Overview 77
5.29.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 77
5.30 Nano Retina, Inc. Company Overview 79
5.30.1 Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Novartis AG Company Overview 80
5.31.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Ocular Dynamics, LLC Company Overview 83
5.32.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.33 Ocutec Limited Company Overview 84
5.33.1 Ocutec Limited Pipeline Products & Ongoing Clinical Trials Overview 84
5.34 PixelOptics, Inc. Company Overview 85
5.34.1 PixelOptics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.35 Pixium Vision Company Overview 86
5.35.1 Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview 86
5.36 Presbia Plc Company Overview 87
5.36.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview 87
5.37 Queensland University of Technology Company Overview 90
5.37.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 90
5.38 ReVision Optics, Inc. Company Overview 91
5.38.1 ReVision Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.39 Stanford University Company Overview 95
5.39.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Tel Aviv University Company Overview 96
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 The Hong Kong University of Science and Technology Company Overview 97
5.41.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 97
5.42 The Johns Hopkins University Company Overview 98
5.42.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 98
5.43 UltraVision CLPL Company Overview 100
5.43.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 100
5.44 University of Auckland Company Overview 101
5.44.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 101
5.45 University of California, San Diego Company Overview 103
5.45.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 103
5.46 University of Florida Company Overview 105
5.46.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 105
5.47 University of Oxford Company Overview 106
5.47.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 106
5.48 University of Rochester Company Overview 108
5.48.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 108
5.49 University of Tennessee, Knoxville Company Overview 110
5.49.1 University of Tennessee, Knoxville Pipeline Products & Ongoing Clinical Trials Overview 110
5.50 University of Valencia Company Overview 112
5.50.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 112
5.51 University of Washington Company Overview 114
5.51.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 114
5.52 Visioneering Technologies, Inc. Company Overview 117
5.52.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.53 VISTAKON Pharmaceuticals, LLC Company Overview 123
5.53.1 VISTAKON Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 Visual Pathways, Inc. (Inactive) Company Overview 124
5.54.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Visus Technology, Inc. Company Overview 126
5.55.1 Visus Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
5.56 Yolia Health Company Overview 127
5.56.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview 127
5.57 Ziemer Ophthalmic Systems AG Company Overview 128
5.57.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 128
5.58 ZircLight Inc. Company Overview 129
5.58.1 ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
6 Vision Care- Recent Developments 131
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213

1.1 List of Tables
Table 1: Vision Care - Pipeline Products by Stage of Development 15
Table 2: Vision Care - Pipeline Products by Segment 16
Table 3: Vision Care - Pipeline Products by Territory 17
Table 4: Vision Care - Pipeline Products by Regulatory Path 18
Table 5: Vision Care - Pipeline Products by Estimated Approval Date 19
Table 6: Vision Care - Ongoing Clinical Trials 20
Table 7: Vision Care Companies - Pipeline Products by Stage of Development 21
Table 8: Vision Care - Pipeline Products by Stage of Development 24
Table 9: Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 10: Corneal Onlay - Product Status 27
Table 11: Corneal Onlay - Product Description 27
Table 12: Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 13: Dailies Total 1 Colors SiHy Lens - Product Status 28
Table 14: Dailies Total 1 Colors SiHy Lens - Product Description 28
Table 15: Dailies Total 1 Multifocal SiHy Lens - Product Status 29
Table 16: Dailies Total 1 Multifocal SiHy Lens - Product Description 29
Table 17: Dailies Total 1 Toric SiHy Lens - Product Status 30
Table 18: Dailies Total 1 Toric SiHy Lens - Product Description 30
Table 19: Weekly WG SiHy Lens - Product Status 31
Table 20: Weekly WG SiHy Lens - Product Description 31
Table 21: Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 32
Table 22: Comfort Lens - Product Status 32
Table 23: Comfort Lens - Product Description 32
Table 24: Contact Lens - Glaucoma - Product Status 33
Table 25: Contact Lens - Glaucoma - Product Description 33
Table 26: Auburn University Pipeline Products & Ongoing Clinical Trials Overview 34
Table 27: Smart Contact Lenses - Product Status 34
Table 28: Smart Contact Lenses - Product Description 34
Table 29: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 30: MC - PHEMA Based Contact Lens - Product Status 35
Table 31: MC - PHEMA Based Contact Lens - Product Description 35
Table 32: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 33: Bionic Eye - Product Status 37
Table 34: Bionic Eye - Product Description 37
Table 35: Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 38
Table 36: Ultra Multi Focal Lens - Product Status 39
Table 37: Ultra Multi Focal Lens - Product Description 39
Table 38: Ultra Plus Powers Lens - Product Status 40
Table 39: Ultra Plus Powers Lens - Product Description 40
Table 40: Ultra Toric Lens - Product Status 41
Table 41: Ultra Toric Lens - Product Description 41
Table 42: Belfanti - Fureder - Meidl technisches Buro f Elektro u Haustechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
Table 43: Stem Cell Contact Lens - Product Status 42
Table 44: Stem Cell Contact Lens - Product Description 42
Table 45: Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview 43
Table 46: High-Acuity Device With 1024 Electrodes - Product Status 43
Table 47: High-Acuity Device With 1024 Electrodes - Product Description 43
Table 48: High-Acuity Device With 256 Electrodes - Product Status 44
Table 49: High-Acuity Device With 256 Electrodes - Product Description 44
Table 50: Wide-View Device With 24-channel - Product Status 45
Table 51: Wide-View Device With 24-channel - Product Description 45
Table 52: Wide-View Device With 44-channel - Product Status 46
Table 53: Wide-View Device With 44-channel - Product Description 46
Table 54: Wide-View Device With 98 Electrodes - Product Status 47
Table 55: Wide-View Device With 98 Electrodes - Product Description 47
Table 56: Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 57: Biolens - Product Status 49
Table 58: Biolens - Product Description 49
Table 59: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 50
Table 60: Contact Lens Drug Delivery Device - Product Status 50
Table 61: Contact Lens Drug Delivery Device - Product Description 50
Table 62: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 51
Table 63: Reduced Optical Instrument - Product Status 52
Table 64: Reduced Optical Instrument - Product Description 52
Table 65: CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 66: SiH Multifocal - Product Status 53
Table 67: SiH Multifocal - Product Description 53
Table 68: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 54
Table 69: Prosthetic Retinal Device - Product Status 54
Table 70: Prosthetic Retinal Device - Product Description 54
Table 71: EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 72: EP Global Contact Lens - Product Status 55
Table 73: EP Global Contact Lens - Product Description 55
Table 74: eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
Table 75: evSpex - Product Status 56
Table 76: evSpex - Product Description 56
Table 77: Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
Table 78: Drug-Eluting Contact Lenses - Product Status 57
Table 79: Drug-Eluting Contact Lenses - Product Description 57
Table 80: Eyegenix Pipeline Products & Ongoing Clinical Trials Overview 58
Table 81: Eyegenix Artificial Cornea - Product Status 58
Table 82: Eyegenix Artificial Cornea - Product Description 58
Table 83: EyeNetra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 84: NETRA G - Product Status 59
Table 85: NETRA G - Product Description 59
Table 86: Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 60
Table 87: Drug Dispensing Contact Lens - Product Status 60
Table 88: Drug Dispensing Contact Lens - Product Description 60
Table 89: EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 61
Table 90: DSPEK - Product Status 61
Table 91: DSPEK - Product Description 61
Table 92: Hyper-CL - Product Status 62
Table 93: Hyper-CL - Product Description 62
Table 94: EyeYon Medical - Ongoing Clinical Trials Overview 63
Table 95: Hyper-CL - Prospective, Randomized Crossover Study Of The Hyper-CL Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema 64
Table 96: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 65
Table 97: Contact Lens - Product Status 65
Table 98: Contact Lens - Product Description 65
Table 99: iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 66
Table 100: STARvue - Product Status 66
Table 101: STARvue - Product Description 66
Table 102: Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 103: 1-DAY ACUVUE Multifocal Contact Lens - Product Status 68
Table 104: 1-DAY ACUVUE Multifocal Contact Lens - Product Description 68
Table 105: ACUVUE OASYS With HydraLuxe Technology - Product Status 69
Table 106: ACUVUE OASYS With HydraLuxe Technology - Product Description 69
Table 107: Anti-allergic Contact Lens - Product Status 70
Table 108: Anti-allergic Contact Lens - Product Description 70
Table 109: Next Generation 1-DAY ACUVUE DEFINE Contact Lens - Product Status 71
Table 110: Next Generation 1-DAY ACUVUE DEFINE Contact Lens - Product Description 71
Table 111: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
Table 112: Therapeutic Contact Lens - Product Status 72
Table 113: Therapeutic Contact Lens - Product Description 72
Table 114: Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 73
Table 115: PTMC Scleral Buckle - Product Status 73
Table 116: PTMC Scleral Buckle - Product Description 73
Table 117: Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview 74
Table 118: First Aid Lens - Product Status 74
Table 119: First Aid Lens - Product Description 74
Table 120: Healing Lens - Product Status 75
Table 121: Healing Lens - Product Description 75
Table 122: Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
Table 123: MicroBioSensor-Contact Lens - Product Status 76
Table 124: MicroBioSensor-Contact Lens - Product Description 76
Table 125: Monash University Pipeline Products & Ongoing Clinical Trials Overview 77

1.2 List of Figures
Figure 1: Vision Care - Pipeline Products by Stage of Development 15
Figure 2: Vision Care - Pipeline Products by Segment 16
Figure 3: Vision Care - Pipeline Products by Territory 17
Figure 4: Vision Care - Pipeline Products by Regulatory Path 18
Figure 5: Vision Care - Pipeline Products by Estimated Approval Date 19
Figure 6: Vision Care - Ongoing Clinical Trials 20

【掲載企業】

Adventus Technology Inc
Alcon, Inc.
Apeliotus Ophthalmics
Auburn University
Axcelon Biopolymers Corp.
Bar-Ilan University
Bausch & Lomb Incorporated
Belfanti - Fureder - Meidl technisches Buro f Elektro u Haustechnik GmbH
Bionic Vision Australia
Body Organ Biomedical Corp.
Children's Hospital Boston
Consejo Superior de Investigaciones Cientificas
CooperVision, Inc.
Cornell University
EP Global Communications, Inc.
eSight Corporation
Euclid Systems Corporation
Eyegenix
EyeNetra, Inc.
Eyenovations
EyeYon Medical
Imperial College London
iSTAR Medical
Johnson & Johnson Vision Care, Inc.
Massachusetts Eye and Ear Infirmary
Medisse BV
Mercy Research and Development
Microbiosensor Ltd
Monash University
Nano Retina, Inc.
Novartis AG
Ocular Dynamics, LLC
Ocutec Limited
PixelOptics, Inc.
Pixium Vision
Presbia Plc
Queensland University of Technology
ReVision Optics, Inc.
Stanford University
Tel Aviv University
The Hong Kong University of Science and Technology
The Johns Hopkins University
UltraVision CLPL
University of Auckland
University of California, San Diego
University of Florida
University of Oxford
University of Rochester
University of Tennessee, Knoxville
University of Valencia
University of Washington
Visioneering Technologies, Inc.
VISTAKON Pharmaceuticals, LLC
Visual Pathways, Inc. (Inactive)
Visus Technology, Inc.
Yolia Health
Ziemer Ophthalmic Systems AG
ZircLight Inc.

【レポートのキーワード】

ビジョンケア機器

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のビジョンケア機器開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆